Skip to main content

Table 2 Analysis the HSP70 protein expression levels in early stage LSCC and than in late stage LSCC

From: HSP70: a promising target for laryngeal carcinoma radiaotherapy by inhibiting cleavage and degradation of nucleolin

  

HSP70 expression levels

 

Clinicopathological parameter

n

0

1+

2+

3+

P

stage I - II

21

2

6

10

3

 

stage III - IV

29

0

1

19

9

0.015